International Flavors (IFF) Q1 Earnings and Revenues Beat Estimates
📈 International Flavors (IFF) reported Q1 earnings of $1.25 per share, beating the Zacks Consensus Estimate of $1.08 per share.
💰 This represents a 16.01% positive earnings surprise compared to last quarter's negative surprise of -5.88%.
📊 The company generated $2.74 billion in revenue for the quarter, which exceeded consensus estimates by 3.44%.
🏆 IFF has surpassed consensus EPS and revenue estimates three out of the last four quarters.
📉 Stock performance context shows IFF shares added about 4% YTD versus the S&P 500's gain of 5.2%.
⚖️ Current estimate revisions are mixed, resulting in a Zacks Rank #3 (Hold) for the stock.
💡 Future stock movement depends on management commentary and potential changes in earnings estimate trends.
🔮 The current consensus EPS expectation is $1.15 for the next quarter on $2.74 billion in revenue.
🏭 IFF belongs to the Zacks Chemical - Specialty industry, which is ranked in the bottom 27% of all industries.
📅 Peer company Neo Performance Materials (NOPMF) is scheduled to report earnings on May 12.
🚀 NOPMF is expected to show a significant 137.5% year-over-year increase in earnings per share of $0.19.
💹 NOPMF's revenue is projected at $130.33 million, representing a 7.2% increase from the prior year.
- International Flavors reported quarterly earnings of $1.25 per share, beating the Zacks Consensus Estimate of $1.08 per share by 16.01%.
- The company surpassed consensus revenue estimates for four consecutive quarters with Q1 revenues reaching $2.74 billion.
- Over the last four quarters, IFF has beaten earnings estimates three times, demonstrating a consistent track record of meeting or exceeding analyst expectations.
- IFF shares have gained about 4% since the beginning of the year, outperforming the market momentum relative to its peer group expectations.
- The company belongs to the Zacks Chemical - Specialty industry, which offers exposure to food, cosmetics, and consumer products sectors.
- International Flavors shares have underperformed the broader market, gaining only about 4% since the start of the year versus the S&P 500's gain of 5.2%.
- The Zacks Industry Rank for Chemical - Specialty places it in the bottom 27% of industries, a sector where research indicates underperformance relative to the top half.
- Ahead of the earnings release, estimate revision trends were mixed, resulting in a Zacks Rank #3 (Hold) which implies shares are expected to merely track with the market rather than outperform.
- While quarterly revenue fell year-over-year to $2.74 billion from $2.84 billion, this decline occurred despite beating consensus estimates by 3.44%.